In November 2018, the Monash Warwick Alliance funded Chemists to develop and identify cost-effective, highly active, selective and stable catalysts. Check their progress...

Researchers at the Universities of Warwick and Nottingham have received EPSRC funding to launch a ground-breaking research programme for global specialist chemical manufacturer, Lubrizol.

The University of Warwick spin-out company, CryoLogyx, has received a further investment from Oxford Technology Management and private investors, alongside £300k from InnovateUK.

A new biotechnology company, CryoLogyx, has been spun-out from the department, supported from a grant from InnovateUK. Cryologyx will be led by Dr Tom Congdon (A UoW UG and PG alumus) and will exploit technology developed by the GibsonGroup. Cryologyx will use innovative macromolecular (polymeric) cryoprotectants to protect biological samples, including cells used in therapy, diagnostics and drug discovery.

Read the news story here and more details will be released soon.